Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes.

PubWeight™: 0.79^‹?›

🔗 View Article (PMID 25555385)

Published in Nicotine Tob Res on January 02, 2015

Authors

Frank C Bandiera¹, Kathryn C Ross¹, Seyedehtaraneh Taghavi², Kevin Delucchi³, Rachel F Tyndale⁴, Neal L Benowitz⁵

Author Affiliations

1: Center for Tobacco Control Research and Education, School of Medicine, University of California, San Francisco, CA;
2: Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada;
3: Department of Psychiatry, University of California, San Francisco, CA;
4: Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada;
5: Center for Tobacco Control Research and Education, School of Medicine, University of California, San Francisco, CA; Division of Clinical Pharmacology and Experimental Therapeutics, Medical Service, San Francisco General Hospital Medical Center, Departments of Medicine, Bioengineering and Therapeutic Sciences and the Center for Tobacco Control Research and Education, University of California, San Francisco, CA neal.benowitz@ucsf.edu.

Associated clinical trials:

REN-Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors | NCT03185546

Articles citing this ↘

Predictors of the nicotine reinforcement threshold, compensation, and elasticity of demand in a rodent model of nicotine reduction policy. Drug Alcohol Depend (2015) 0.87

The tobacco endgame: a qualitative review and synthesis. Tob Control (2015) 0.76

Reduced-Nicotine Cigarettes in Young Smokers: Impact of Nicotine Metabolism on Nicotine Dose Effects. Neuropsychopharmacology (2017) 0.75

Reduced nicotine content cigarette advertising: How false beliefs and subjective ratings affect smoking behavior. Drug Alcohol Depend (2017) 0.75

Articles cited by this ↗

A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature (2008) 18.21

Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict (1989) 11.63

Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med (1994) 6.75

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet (2010) 6.49

Time to first cigarette in the morning as an index of ability to quit smoking: implications for nicotine dependence. Nicotine Tob Res (2007) 5.54

Nicotine addiction. N Engl J Med (2010) 4.13

Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther (2004) 3.49

Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction (2010) 3.26

Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res (2011) 3.25

The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Res (2009) 2.63

Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion. Clin Pharmacol Ther (2008) 2.49

Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clin Pharmacol Ther (2006) 2.49

Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomarkers Prev (2007) 2.43

Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J Chromatogr B Analyt Technol Biomed Life Sci (2010) 2.25

CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Clin Pharmacol Ther (2006) 2.21

Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. J Neurogenet (2009) 2.07

Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev (2012) 2.06

Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav (2008) 1.90

Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokers. Clin Pharmacol Ther (2009) 1.83

Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry. Anal Chem (2007) 1.69

Reducing tobacco addiction through tobacco product regulation. Tob Control (2004) 1.59

Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol (2012) 1.34

Nicotine reduction: strategic research plan. Nicotine Tob Res (2012) 1.27

Exposure and kinetics of polycyclic aromatic hydrocarbons (PAHs) in cigarette smokers. Chem Res Toxicol (2012) 1.17

The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex. Cancer Epidemiol Biomarkers Prev (2013) 1.13

The reinforcement threshold for nicotine as a target for tobacco control. Drug Alcohol Depend (2012) 0.94

CHRNA5-A3-B4 genetic variants alter nicotine intake and interact with tobacco use to influence body weight in Alaska Native tobacco users. Addiction (2013) 0.83